Catalyst Pharmaceuticals is a American stock, trading under the symbol CPRX-Q on the NASDAQ (CPRX). It is usually referred to as NASDAQ:CPRX or CPRX-Q
In the last year, 1 stock analyst published opinions about CPRX-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Catalyst Pharmaceuticals.
Catalyst Pharmaceuticals was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Catalyst Pharmaceuticals.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Catalyst Pharmaceuticals published on Stockchase.
On 2023-12-01, Catalyst Pharmaceuticals (CPRX-Q) stock closed at a price of $14.82.
Should be higher. They make a lot of money and beat their quarter.